Search
MindWalk Holdings Ord Shs
HYFTAdd to Watchlist
1.560USD
-0.060-3.70%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
72.88MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
3
analysts
Buy
Current Rating
4.000
Target Price
+140.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
MindWalk Holdings Ord Shs
HYFT
3
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
Eli Lilly and Co
LLY
34
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is MindWalk Holdings Ord Shs's expected revenue for the next quarter?
MindWalk Holdings Ord Shs's expected revenue is 4.41M.
What is MindWalk Holdings Ord Shs's price target?
Analysts forecast that MindWalk Holdings Ord Shs's price target is USD 4.00, with the highest forecast at USD 5.00 and the lowest forecast at USD 3.00.
How have MindWalk Holdings Ord ShsHYFT's recent earnings per share performed?
The market expectation was USD -0.06, while MindWalk Holdings Ord ShsHYFT's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for MindWalk Holdings Ord Shs?
Based on the ratings of MindWalk Holdings Ord Shs's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.